UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-A

 

 

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR 12(g) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

 

AC IMMUNE SA

(Exact Name of Registrant as Specified in Its Charter)

 

 

 

Switzerland

(State of Incorporation or Organization)

 

Not Applicable

(I.R.S. Employer Identification No.)

EPFL Innovation Park, Building B  

Lausanne, Switzerland

(Address of Principal Executive Offices)

 

1015

(Zip Code)

Securities to be registered pursuant to Section 12(b) of the Act:

 

Title of Each Class

to be so Registered

 

Name of Each Exchange on Which

Each Class is to be Registered

Common shares, nominal value CHF 0.02 per share   The NASDAQ Stock Market LLC

 

 

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), please check the following box. x :

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to General Instruction A.(d), please check the following box. ¨

Securities Act registration statement file number to which this form relates:

333-211714

(If applicable)

Securities to be registered pursuant to Section 12(g) of the Act:

(Title of Class)

N/A

 

 

 


Item 1: Description of Registrant’s Securities to be Registered

The description under the heading “Description of Share Capital and Articles of Association” relating to the Registrant’s common shares, CHF 0.02 nominal value per share (the “Common Shares”), in the prospectus included in the Registrant’s Registration Statement on Form F-1 (Registration No. 333-211714) originally filed with the Securities and Exchange Commission on May 31, 2016, as amended (the “Registration Statement”), is incorporated by reference herein. In addition, the description that will be included under the heading “Description of Share Capital and Articles of Association” relating to the Common Shares in the Registrant’s final prospectus relating to the Registration Statement to be subsequently filed with the Securities and Exchange Commission pursuant to Rule 424(b) under the Securities Act of 1933, as amended, shall be incorporated by reference herein.

 

Item 2: Exhibits

Pursuant to the Instructions as to Exhibits with respect to Form 8-A, no exhibits are required to be filed because no other securities of the Registrant are registered on The NASDAQ Stock Market LLC and the securities registered hereby are not being registered pursuant to Section 12(g) of the Securities Exchange Act of 1934, as amended.


SIGNATURE

Pursuant to the requirements of Section 12 of the Securities Exchange Act of 1934, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereto duly authorized.

 

AC IMMUNE SA
By:  

/s/ Andrea Pfeifer

  Name:   Andrea Pfeifer
  Title:   Chief Executive Officer
By:  

/s/ George Pavey

  Name:   George Pavey
  Title:   Chief Financial Officer

Date: September 23, 2016

AC Immune (NASDAQ:ACIU)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more AC Immune Charts.
AC Immune (NASDAQ:ACIU)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more AC Immune Charts.